| Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation X Hu, Y Zhang, Y Xue, Z Zhang, J Wang American journal of translational research 10 (11), 3322, 2018 | 45 | 2018 |
| Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study Y Luan, Y Zhang, SY Yu, M You, PC Xu, S Chung, T Kurita, J Zhu, SY Kim Journal of cachexia, sarcopenia and muscle 13 (2), 1289-1301, 2022 | 20 | 2022 |
| FOXK2 promotes ovarian cancer stemness by regulating the unfolded protein response pathway Y Zhang, Y Wang, G Zhao, EJ Tanner, M Adli, D Matei The Journal of Clinical Investigation 132 (10), 2022 | 17 | 2022 |
| Metabolic dependencies and targets in ovarian cancer Y Zhang, Y Wang, G Zhao, S Orsulic, D Matei Pharmacology & Therapeutics, 108413, 2023 | 16 | 2023 |
| Magnetic resonance imaging monitoring therapeutic response to dendritic cell vaccine in murine orthotopic pancreatic cancer models L Pan, N Shang, J Shangguan, M Figini, W Xing, B Wang, C Sun, J Yang, ... American journal of cancer research 9 (3), 562, 2019 | 15 | 2019 |
| MRI assessment of associations between brown adipose tissue and cachexia in murine pancreatic ductal adenocarcinoma Y Zhang, S Hu, J Shangguan, L Pan, X Zhou, V Yaghmai, Y Velichko, ... Internal medicine: open access 9 (1), 2019 | 11 | 2019 |
| A tiered female ovarian toxicity screening identifies toxic effects of checkpoint kinase 1 inhibitors on murine growing follicles J Xu, Y Wang, AE Kauffman, Y Zhang, Y Li, J Zhu, K Maratea, K Fabre, ... Toxicological Sciences 177 (2), 405-419, 2020 | 9 | 2020 |
| Lung metastases from intracranial bleeding meningioma: A case report S Hu, Y Zhang, Y Sun, Y Yu, J Wang, H Dai, F Sun, C Hu Medicine 97 (16), e0457, 2018 | 8 | 2018 |
| Non-invasive imaging methods for brown adipose tissue detection and function evaluation Y Zhang, X Hu, S Hu, A Scotti, K Cai, J Wang, X Zhou, D Yang, M Figini, ... Internal medicine: open access 8 (6), 2018 | 5 | 2018 |
| DOT1 L regulates ovarian cancer stem cells by activating β-catenin signaling Y Zhang, Y Wang, A Valdivia, H Huang, D Matei Molecular Cancer Research 21 (2), 140-154, 2023 | 4 | 2023 |
| FOXK2 and DOT1L as Novel Therapeutic Targets for Ovarian Cancer Stem Cells Y Zhang Northwestern University, 2022 | 1 | 2022 |
| Metabolic characteristics of granulosa cell tumor: role of PPARγ signaling SY Yu, Y Luan, PC Xu, Y Zhang, R Dong, A Abazarikia, SY Kim Biology of Reproduction 110 (3), 509-520, 2024 | | 2024 |
| Nanoparticle Targeting in Chemo‐Resistant Ovarian Cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance Y Wang, AE Calvert, H Cardenas, JS Rink, D Nahotko, W Qiang, ... Advanced Science, 2305212, 2024 | | 2024 |
| FOXK2 promotes stemness in ovarian cancer by regulating unfolded protein response signaling Y Zhang, Y Wang, G Zhao, EJ Tanner, M Adli, DE Matei Cancer Research 82 (12_Supplement), 6063-6063, 2022 | | 2022 |
| Targeting ovarian cancer stem cell by Dot1L inhibition. Y Zhang, Y Wang, G Zhao, D Matei CLINICAL CANCER RESEARCH 26 (13), 79-79, 2020 | | 2020 |
| Abstract A80: Targeting ovarian cancer stem cell by Dot1L inhibition Y Zhang, Y Wang, G Zhao, D Matei Clinical Cancer Research 26 (13_Supplement), A80-A80, 2020 | | 2020 |
| Stage-specific muscle wasting mechanisms in a novel cancer cachexia mouse model for ovarian granulosa cell tumor Y Zhang, J Zhu, SY Kim, MM Romero, KA Even, T Kurita, TK Woodruff bioRxiv, 2020.06. 16.154385, 2020 | | 2020 |
| Cancer Cachexia, September 23–25, 2016 in Washington, DC, USA DC Guttridge, J Argiles, TA Zimmers Journal of Cachexia, Sarcopenia and Muscle 8, 145-160, 2017 | | 2017 |
